IL317723A - N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides - Google Patents

N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides

Info

Publication number
IL317723A
IL317723A IL317723A IL31772324A IL317723A IL 317723 A IL317723 A IL 317723A IL 317723 A IL317723 A IL 317723A IL 31772324 A IL31772324 A IL 31772324A IL 317723 A IL317723 A IL 317723A
Authority
IL
Israel
Prior art keywords
hexan
carboxamides
oxoethyl
azabicyclo
quinoline
Prior art date
Application number
IL317723A
Other languages
Hebrew (he)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL317723A publication Critical patent/IL317723A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL317723A 2022-06-21 2023-06-20 N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides IL317723A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263366700P 2022-06-21 2022-06-21
PCT/EP2023/066560 WO2023247488A1 (en) 2022-06-21 2023-06-20 N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides

Publications (1)

Publication Number Publication Date
IL317723A true IL317723A (en) 2025-02-01

Family

ID=87047759

Family Applications (1)

Application Number Title Priority Date Filing Date
IL317723A IL317723A (en) 2022-06-21 2023-06-20 N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides

Country Status (19)

Country Link
US (1) US20230406840A1 (en)
EP (1) EP4543869B1 (en)
JP (1) JP2025525345A (en)
KR (1) KR20250044660A (en)
CN (1) CN119562947A (en)
AR (1) AR129669A1 (en)
AU (1) AU2023288735A1 (en)
CA (1) CA3260241A1 (en)
CL (1) CL2024003889A1 (en)
CO (1) CO2025000307A2 (en)
CR (1) CR20250020A (en)
DO (1) DOP2024000266A (en)
IL (1) IL317723A (en)
MA (1) MA71235A (en)
MX (1) MX2024015642A (en)
PE (1) PE20251704A1 (en)
TW (1) TW202417422A (en)
UY (1) UY40322A (en)
WO (1) WO2023247488A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1760076A1 (en) * 2005-09-02 2007-03-07 Ferring B.V. FAP Inhibitors
EP1931633A2 (en) 2005-09-05 2008-06-18 Ranbaxy Laboratories Limited Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors
CN113811529A (en) * 2018-12-21 2021-12-17 普拉西斯生物技术有限责任公司 fibroblast-activated protein inhibitor

Also Published As

Publication number Publication date
AR129669A1 (en) 2024-09-18
AU2023288735A1 (en) 2025-02-13
CN119562947A (en) 2025-03-04
JP2025525345A (en) 2025-08-05
CL2024003889A1 (en) 2025-02-07
EP4543869A1 (en) 2025-04-30
WO2023247488A1 (en) 2023-12-28
CO2025000307A2 (en) 2025-01-23
PE20251704A1 (en) 2025-07-02
MA71235A (en) 2025-04-30
CA3260241A1 (en) 2023-12-28
EP4543869B1 (en) 2026-05-27
DOP2024000266A (en) 2025-07-15
US20230406840A1 (en) 2023-12-21
CR20250020A (en) 2025-05-26
KR20250044660A (en) 2025-04-01
UY40322A (en) 2023-12-15
TW202417422A (en) 2024-05-01
MX2024015642A (en) 2025-02-10

Similar Documents

Publication Publication Date Title
EP4081828A4 (en) SCALING PARAMETERS FOR V-PCC
MA54526A (en) NEW POLYMORPHIC FORMS OF A TGFBeta INHIBITOR
EP3781357A4 (en) IMPROVED LIFTING MECHANISM FOR FRAMING NAILER
EP4116039A4 (en) DRIVE MACHINE
EP3919491A4 (en) AKT INHIBITOR
EP3898654A4 (en) FIBROBLAST ACTIVATING PROTEIN INHIBITORS
EP3941612A4 (en) CARBON AIRGEL CATHODES FOR LITHIUM-SULFUR BATTERIES
EP3998003A4 (en) WATER-BASED ADHESIVE FOR PAPER STRAW, AND PAPER STRAW USING THE SAME
EP3915262A4 (en) ENCODER, DECODER AND RELATED METHODS FOR INTERPREDICTION
AU2021390923A9 (en) "livestock monitoring"
EP3952861A4 (en) POLYMORPHIC FORMS OF VORUCICLIB, AND METHODS OF MAKING AND METHODS OF USING THE SAME
EP4234740A4 (en) STEEL PLATE
EP3963995A4 (en) CHANNEL ACCESS PRIORITY SELECTION
IL320582A (en) Heterocyclic carboxylate compounds as glycolate oxidase inhibitors
HK40125947A (en) N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides
CA3260241A1 (en) N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides
HK40102287A (en) N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- quinoline-4-carboxamides
EP3964598A4 (en) GALVANISED STEEL
IL317722A (en) Solid-state forms of n-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- 6-morpholinoquinoline-4-carboxamide
IL291187A (en) Benzyl amine-containing 5,6-heteroaromatic compounds useful against mycobacterial infection
EP4085954A4 (en) ANESTHESIA MACHINE
EP4036059A4 (en) COMPOSITION FOR FORMING TIN OXIDE
EP3996252A4 (en) DRIVE UNIT
CA211415S (en) Coffret en forme d'hippopotame
GB202314204D0 (en) 0/.9. f13/9.23